Contact HIV/AIDS
Info on HIV/AIDS:
206-205-7837
TTY: 206-296-4843
Toll-free: 800-678-1595
Administration:
206-296-4649
HIV/STD Testing
HIV/STD Hotline:
206-205-7837 or
Toll-free: 800-678-1595
11:00 am to 4:00 pm
Monday - Friday for
testing information, resources and referrals
|
|
HIV/AIDS Program
Bibliographies for August 2000
Men Who Have Sex With Men
|
| 1. |
Valleroy LA, MacKellar DA, et al. HIV Prevalence and Associated Risks in Young Men Who Have Sex with Men. JAMA, July 12, 2000;284(2):198.
|
| 2. |
Diaz RM, Ayala G and Marin BV. Latino Gay Men and HIV: Risk Behavior as a Sign of Oppression. Focus, June 2000;15(7):1-8.
|
| 3. |
Grulich A (editorial). HIV risk behaviour in gay men: on the rise? BMJ, June 3, 2000;320:1487-1488.
|
| 4. |
Waldo CR, Stall RD, and Coates TJ. Is offering post-exposure prevention for sexual exposures to HIV related to sexual risk behavior in gay men? AIDS, 2000;14:1035-1039.
|
| 5. |
Goldie SJ, Kuntz KM, et al. Cost-effectiveness of Screening for Anal Squamous Intraepithelial Lesions and Anal Cancer in HIV-negative Homosexual and Bisexual Men. Am J Med, 2000;108:634-641.
|
| 6. |
HIV/AIDS Among Men Who Have Sex with Men and Inject Drugs—United States, 1985-1998. MMWR, June 2, 2000;49(21):465-470.
|
| 7. |
Donovan B and Ross MW. Preventing HIV: determinants of sexual behaviour. Lancet, May 27, 2000;355:1897-1901.
|
| 8. |
Tate FB and Longo DA. HIV/AIDS Prevention: A Model for Educating the Inpatient Psychiatric Population. AIDS Patient Care and STDs, 2000;14(6):325-331.
|
| 9. |
Szabo R and Short RV. How does male circumcision protect against HIV infection? BMJ, June 10, 2000;320:1592-1594.
|
| 10. |
Singh J. The Readability of HIV/AIDS Education Materials. AIDS Education & Prevention, 2000;12(3):214-224.
|
| 11. |
Williams MI, Freeman RC, et al. A Comparison of the Realiability of Self-reported Drug Use and Sexual Behaviors Using Computer-assisted Versus Face-to-face Interviewing. AIDS Education & Prevention, 2000;12(3):199-213.
|
| 12. |
Adoption of Protective Behaviors Among Persons with Recent HIV Infection and Diagnosis-—Alabama, New Jersey, and Tennessee, 1997-1998. MMWR, June 16, 2000;49(23):512-515.
|
| 13. |
Whitaker, DJ, Miller KS, and Clark LF. Reconceptualizing Adolescent Sexual Behavior: Beyond ‘Did They or Didn’t They.’ Family Planning Perspectives. May/June 2000;32(3):111-117.
|
| 14. |
Norman C. HIV and Africa’s Future. Science, June 23, 2000;288:2149-2178.
|
| 15. |
Ainsworth M and Teokul W. Breaking the silence: setting realistic priorities for AIDS control in less-developed countries. Lancet, July 1, 2000;356:55-60.
|
| 16. |
Wood E, Braitstein P, et al. Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet, June 17, 2000;355:2095-2100.
|
| 17. |
Egger M, Pauw J, et al. Promotion of condom use in a high-risk setting in Nicaragua: a randomised controlled trial. Lancet, June 17, 2000;355:2101-2105.
|
| 18. |
Wilkinson D, Abdool Karim SS, et al. High HIV Incidence and Prevalence Among Young Women in Rural South Africa: Developing a Cohort for Intervention Trials. J AIDS, 2000;23:405-409.
|
| 19. |
Van de Wijgert JHHM, Chirenje ZM, et al. Effect of Intravaginal Practices on the Vaginal and Cervical Mucosa of Zimbabwean Women. J AIDS, 2000;24:62-67.
|
| 20. |
Mitton J. The Sociological Spread of HIV/AIDS in South Africa. J Assn Nurses AIDS Care, July/August 2000;11(4):17-26.
|
| 21. |
Delaney M. HIV, AIDS, and the Distortion of Science. Focus, May 2000;15(6):1-8.
|
| 22. |
Ball SC. Addressing the Issue of Childbearing in Heterosexual Couples Discordant for HIV. AIDS Reader, 2000;10(3):144-145.
|
| 23. |
Esparza J and Bhamarapravati N. Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how? Lancet, June 10, 2000;355:2061-2066.
|
| 24. |
Bayer R. Ethical challenges of HIV vaccine trials in less-developed nations: conflict and consensus in the international arena. AIDS, 2000;14:1051-1057.
|
| 25. |
Chase A and Tighe J (editors). Mental Illness. HIV Counselor Perspectives, June 2000;9(3):1-8.
|
| 26. |
Thomas DJ, Astemborski J, et al. The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors. JAMA, July 26, 2000;284(4):450-456.
|
| 27. |
Hepatitis C Virus Infection Among Firefighters, Emergency Medical Technicians, and Paramedics—Selected Locations, United States, 1991-2000. MMWR, July 28, 2000;49(29):660-665.
|
| 28. |
Malik AH and Lee WM. Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium. Ann Intern Med, 2000;132(9):723-731.
|
| 29. |
Bower WA, Nainan OV, et al. Duration of Hepatitis A Virus Infection. J Inf Dis, July 2000;182:000-000.
|
| 30. |
Voluntary HIV-1 Counseling & Testing Efficacy Study Group. Efficacy of Voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet, July 8, 2000;356:103-112.
|
| 31. |
Sweat M, Gregorich S, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet, 2000;356:113-121.
|
| 32. |
Van de Perre P (commentary). HIV voluntary counselling and testing in community health services. Lancet, 2000;356:86-87.
|
| 33. |
Ball SC. Clinical Challenge: Understanding HIV Test Results. AIDS Reader, 2000;10(5):265-267.
|
| 34. |
Mofenson LM and McIntyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet, June 24, 2000;355:2237-2244.
|
| 35. |
Latham MC and Preble EA. Appropriate feeding methods for infants of HIV-infected mothers in sub-Saharan Africa. BMJ, June 17, 2000;320:1656-1660.
|
| 36. |
Dabis F, Leroy V, et al. Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000. AIDS, 2000;14:1017-1026.
|
| 37. |
Kuhn L, Abrams EJ, et al. Disease Progession and Early Viral Dynamics in HIV-infected Children Exposed to Zidovudine during Prenatal and Perinatal Periods. J Inf Dis, 2000;182:000-000.
|
Sexually Transmitted Diseases
|
| 38. |
McFarlane M, Bull SS and Rietmeijer CA. The Internet as a Newly Emerging Risk Environment for STDs. JAMA, July 26, 2000;284(4):443-446.
|
| 39. |
Toomey KE and Rothenberg RB. Sex and Cyberspace—Virtual Networks Leading to High-Risk Sex. JAMA, July 26, 2000;284(4):485-487.
|
| 40. |
Golden MR, Schillinger JA, et al. Duration of Untreated Genital Infections with Chlamydia trachomatis: A review of the literature. Sex Trans Dis, July 2000;27(6):329-337.
|
| 41. |
Gaydos CA, Quinn TC and Gaydos JC. The Challenge of STDs for the Military: What Has Changed? Clinical Inf Dis, 2000;30:719-722.
|
| 42. |
Grosskurth H, Gray R, et al. Control of STDs for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet, June 3, 2000;355:1981-1987.
|
| 43. |
Chesson HW and Pinkerton SD. STDs and the Increased Risk for HIV Transmission: Implications for Cost-Effectiveness Analyses of STD Prevention Interventions. J AIDS, 2000;24:48-56.
|
Anti-Retroviral Treatment
|
| 44. |
Harrington M and Carpenter CCJ. Hit HIV-1 hard, but only when necessary. Lancet, June 17, 2000;355:2147-2152.
|
| 45. |
Vella S. Structured Treatment Interruptions and Treatment intensification. AIDS Clinical Care, July 2000;12(7):55-57.
|
| 46. |
Cheonis N. Structured Treatment Interruption: Future Protocol or Wishful Thinking? BETA, Spring 2000:32-38.
|
| 47. |
Dupont C, Vasseur E, et al. Long-term efficacy on Kaposi’s sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. AIDS, 2000;14:987-993.
|
| 48. |
Sabin CA, Yee TT, et al. Two decades of HIV infection in a cohort of haemophiliac individuals: clinical outcomes and response to highly active antiretroviral therapy. AIDS, 2000;14:1001-1007.
|
| 49. |
Kennedy SB. Developing a Self-Administered Tool to Predict Adherence to Antiretroviral Therapy: Design, Method, and Objectives. AIDS Patient Care and STDs, 2000;14(6):309-315.
|
| 50. |
Gifford AL, Bormann JE, et al. Predictors of Self-Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens. J AIDS, 2000;23:386-395.
|
| 51. |
Paterson DL, Swindells S, et al. Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection. Ann Intern Med, 2000;133:21-30.
|
| 52. |
Riley ED, Safaeian M, et al. Comparing New Participants of a Mobile Versus a Pharmacy-based Needle Exchange Program. J AIDS, 2000;24:57-61.
|
| 53. |
Doherty MC, Junge B, et al. The Effect of a Needle Exchange Program on Numbers of Discarded Needles: A 2-year Follow-up. Am J Public Health, June 2000;90(6):936-939.
|
| 54. |
Boot BP, McGregor IS and Hall W. MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks. Lancet, May 20, 2000;355:1818-1821.
|
| 55. |
Nemoto T, Aoki B, et al. HIV Risk Behaviors Among Asian Drug Users in San Francisco. AIDS Education & Prevention, 2000;12(2):126-140.
|
| 56. |
Wood E, Schechter MT, et al. Antiretroviral medication use among injection drug users: two potential futures. AIDS, 2000;14:1229-1235.
|
| 57. |
Welch KJ. Correlates of Alcohol and/or Drug Use Among HIV-infected Individuals. AIDS Patient Care and STDs, 2000;14(6):317-323.
|
| 58. |
O’Connor PG and Fiellin DA. Pharmacologic Treatment of Heroin-Dependent Patients. Ann Intern Med, 2000;133:40-54.
|
| 59. |
Unintentional Opiate Overdose Deaths—King County, Washington, 1990-1999. MMWR, July 21, 2000;49(28):636-640.
|
| 60. |
Heroin Overdose Deaths—Multnomah County, Oregon, 1993-1999. MMWR, July 21, 2000;49(28):633-636.
|
HIV/AIDS in People of Color
|
| 61. |
Smith DK, Gwinn M, et al. HIV/AIDS among African Americans: progress or progression? AIDS, 2000;14:1237-1248.
|
| 62. |
Wright K. AIDS and Black New Yorkers (A series of three articles). Village Voice, June 14, 21 & 28, 2000.
|
| 63. |
Dancy BL, Marantonion R and Norr K. The Long Term Effectiveness of an HIV Prevention Intervention for Low Income African American Women. AIDS Education and Prevention, 2000;12(2):113-125.
|
| |
